ELTX
Elicio Therapeutics Inc.
1.90$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -12.4% | -9.8% | -35.7% | +143.7% | -26.6% | -0.1% | +4.9% | -4.2% | -8.6% | -12.3% | +38.1% | |
| – | -18.0% | -13.6% | -52.7% | +358.2% | -32.5% | +1.2% | +7.9% | -5.0% | -10.0% | -16.1% | +57.3% | |
| – | -13.1% | -8.1% | -67.8% | +580.9% | -32.3% | +4.2% | +20.4% | -6.7% | -9.9% | -19.5% | +57.1% | |
| – | -13.1% | -8.1% | -67.8% | +580.9% | -32.3% | +4.2% | +20.4% | -6.7% | -9.9% | -19.5% | +57.1% | |
| – | – | – | – | -97.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -10.9% | +24.3% | -11.3% | +229.7% | -31.2% | -51.3% | +43.9% | -11.6% | -1.0% | -0.4% | -3.0% | |
| – | -15.1% | -39.0% | +27.5% | +18.9% | +27.7% | -1.0% | -13.1% | -34.3% | +24.5% | -10.9% | +27.3% | |
| – | -3.0% | -3.2% | -3.1% | +2.7% | +2.7% | +2.8% | +2.8% | +3.0% | +3.1% | +3.1% | +3.0% | |
| – | -0.8% | -74.7% | -4.5% | +88.1% | -47.7% | +288.9% | -4.3% | -91.7% | +109.3% | -59.5% | +208.5% | |
| – | – | – | – | – | +1.0% | – | – | +4.1% | -3.2% | +0.7% | +0.6% | |
| – | -14.4% | -57.2% | -133.9% | – | – | – | -79.4% | +108.1% | -57.1% | -187.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +135.5% | +7.0% | +9.8% | +20.4% | -10.2% | +6.1% | +24.0% | +3.9% | -8.3% | +18.9% | +5.7% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.